New insights into markers for distinguishing neuroendocrine prostate cancer: evidence from single-cell analysis
BackgroundNeuroendocrine prostate cancer (NEPC) is a highly aggressive malignancy with few effective treatment options. The identification of reliable biomarkers for NEPC is essential for early detection and intervention.MethodsWe combined single-cell …